Application note: Determining the structure of impurities
Most, if not all pharmaceutical companies will have experienced a product, that has been on the market for a long time, to suddenly and unexpectedly trigger a signal for an unknown substance in the quality control (QC) laboratory approval process.
Deciding on the next course of action is of the upmost importance to the company’s success. Ultimately, the most important consideration is product quality and safety, however the financial impact is also a commercial priority too.
Related content from this organisation
- Whitepaper: Detection of mycoplasma in biopharmaceuticals vaccines and gene cell therapies
- Whitepaper: Complex Generic APIS: A Primer
- Application note: Determining the structure of impurities
- Expert view: Choosing the right CRO: why independence and quality culture matter
- QA/QC & Analytical Techniques In-Depth Focus 2019 featuring Microbiology and Chromatography